Artelo Biosciences, Inc.

ARTL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$3-$4-$2-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$1$0-$0$1
Other Non-Cash$0$3$1-$0
Operating Cash Flow-$3-$1-$2-$3
Investing Activities
PP&E Inv.-$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$2$0$0
Inv. Sales/Matur.$0-$3$0$1
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0$0$1
Financing Activities
Debt Repay.$0$1$0$0
Stock Issued$4$1$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0$0$0
Financing Cash Flow$3$2$0$0
Forex Effect-$0$0$0-$0
Net Chg. in Cash-$0$1-$2-$2
Supplemental Information
Beg. Cash$2$1$2$4
End Cash$2$2$1$2
Free Cash Flow-$3-$1-$2-$3
Artelo Biosciences, Inc. (ARTL) Financial Statements & Key Stats | AlphaPilot